Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort

被引:74
作者
Pacheco, Y. M. [1 ]
Jarrin, I. [2 ]
Rosado, I. [1 ]
Campins, A. A. [3 ]
Berenguer, J. [4 ]
Iribarren, J. A. [5 ]
Rivero, M. [6 ]
Munoz-Medina, L. [7 ]
Bernal-Morell, E. [8 ]
Gutierrez, F. [9 ]
Leal, M. [1 ]
机构
[1] Univ Seville, Virgen Rock Univ Hosp, CSIC, Inst Biomed Seville IBiS,Lab Immunovirol,Clin Uni, Seville 41013, Spain
[2] Inst Hlth Carlos III, Madrid, Spain
[3] Hosp Univ Son Espases, Palma de Mallorca, Spain
[4] Gregorio Maranon Gen Univ Hosp, Infect Dis HIV Unit, Madrid, Spain
[5] Hosp Univ Donostia, San Sebastian, Spain
[6] Navarra Hosp, Pamplona, Spain
[7] Hosp Univ San Cecilio, Unidad Enfermedades Infecc, Granada, Spain
[8] Hosp Gen Univ Reina Sofia, Serv Enfermedades Infecc, Madrid, Spain
[9] Univ Miguel Hernandez, Hosp Gen Univ Elche, Dept Clin Med, Infect Dis Unit, Alicante, Spain
关键词
Low-CD4; restoration; Mortality; AIDS; Non-AIDS-defining events; Non-AIDS-defining malignancies; Immunodeficiency; Clinical complications; COMBINATION ANTIRETROVIRAL THERAPY; LONG-TERM MORTALITY; INFECTED PATIENTS; DEFINING MALIGNANCIES; VIRAL SUPPRESSION; CANCER; IMMUNODEFICIENCY; INDIVIDUALS; RECOVERY; PARENTS;
D O I
10.1016/j.antiviral.2015.03.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim was to analyze clinical complications in HIV-infected subjects who persistently maintain low CD4 levels despite virological response to cART in the Spanish CoRIS cohort. The main inclusion criteria were CD4 counts <200 cells/mm(3) at cART-initiation and at least 2 years under cART achieving a viral load <500 copies/mL. Those patients with CD4 counts <250 cells/mm(3) 2 years after cART were classified as the Low-CD4 group, and clinical events were collected from this time-point. Poisson regression models were used to calculate incidence rate ratios of death, AIDS-defining events, serious non-AIDS-defining events (NAE) and of each specific NAE category (non-AIDS-defining malignancies (non-ADM), cardiovascular, kidney- and liver-related events). Of 9667 patients in the cohort, a total of 1128 met the criteria and 287 (25.4%) were classified in the Low-CD4 group. A higher risk of death (aIRR: 4.71; 95% CI: 1.88-11.82; p-value = 0.001) and of non-ADM were observed in this group (aIRR: 2.23; 95% CI: 1.07-4.63; p = 0.03). Our results stress the need to control accelerated aging in this population to counter their increased risk of non-AIDS-defining diseases, particularly cancer, and are consistent with the concept that clinical complications are potentially affected by genetics and lifestyle. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:69 / 74
页数:6
相关论文
共 31 条
[11]   Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis [J].
Grulich, Andrew E. ;
van Leeuwen, Marina T. ;
Falster, Michael ;
Vajdic, Claire M. .
LANCET, 2007, 370 (9581) :59-67
[12]   Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation [J].
Grulich, Andrew E. .
CURRENT OPINION IN HIV AND AIDS, 2009, 4 (03) :183-187
[13]   Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population [J].
Guaraldi, Giovanni ;
Orlando, Gabriella ;
Zona, Stefano ;
Menozzi, Marianna ;
Carli, Federica ;
Garlassi, Elisa ;
Berti, Alessandra ;
Rossi, Elisa ;
Roverato, Alberto ;
Palella, Frank .
CLINICAL INFECTIOUS DISEASES, 2011, 53 (11) :1120-1126
[14]   Poor CD4 response despite viral suppression is associated with increased non-AIDS-related mortality among HIV patients and their parents [J].
Helleberg, Marie ;
Kronborg, Gitte ;
Larsen, Carsten S. ;
Pedersen, Gitte ;
Pedersen, Court ;
Obel, Niels ;
Gerstoft, Jan .
AIDS, 2013, 27 (06) :1021-1026
[15]   Serious Non-AIDS events: Immunopathogenesis and interventional strategies [J].
Hsu, Denise C. ;
Sereti, Irini ;
Ananworanich, Jintanat .
AIDS RESEARCH AND THERAPY, 2013, 10
[16]   Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral Therapy [J].
Kesselring, Anouk ;
Gras, Luuk ;
Smit, Colette ;
van Twillert, Gitte ;
Verbon, Annelies ;
de Wolf, Frank ;
Reiss, Peter ;
Wit, Ferdinand .
CLINICAL INFECTIOUS DISEASES, 2011, 52 (12) :1458-1465
[17]  
Lapadula G., 2013, HIV EXP EXCH M SEV
[18]   Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment [J].
Lapadula, Giuseppe ;
Cozzi-Lepri, Alessandro ;
Marchetti, Giulia ;
Antinori, Andrea ;
Chiodera, Alessandro ;
Nicastri, Emanuele ;
Parruti, Giustino ;
Galli, Massimo ;
Gori, Andrea ;
Monforte, Antonella d'Arminio .
AIDS, 2013, 27 (05) :769-779
[19]   A CD4+ Cell Count &lt;200 Cells per Cubic Millimeter at 2 Years After Initiation of Combination Antiretroviral Therapy Is Associated With Increased Mortality in HIV-Infected Individuals With Viral Suppression [J].
Loutfy, Mona R. ;
Genebat, Miguel ;
Moore, David ;
Raboud, Janet ;
Chan, Keith ;
Antoniou, Tony ;
Milan, David ;
Shen, Anya ;
Klein, Marina B. ;
Cooper, Curtis ;
Machouf, Nima ;
Rourke, Sean B. ;
Rachlis, Anita ;
Tsoukas, Chris ;
Montaner, Julio S. G. ;
Walmsley, Sharon L. ;
Smieja, Marek ;
Bayoumi, Ahmed ;
Mills, Edward ;
Hogg, Robert S. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 55 (04) :451-459
[20]   Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy [J].
Masia, Mar ;
Padilla, Sergio ;
Alvarez, Debora ;
Lopez, Juan C. ;
Santos, Ignacio ;
Soriano, Vicente ;
Hernandez-Quero, Jose ;
Santos, Jesus ;
Tural, Cristina ;
del Amo, Julia ;
Gutierrez, Felix .
AIDS, 2013, 27 (02) :181-189